United Kingdom· GB-APID-42163111000001103
Reboxetine 4mg tablets
A reboxetine product containing reboxetine, registered in United Kingdom by Imported. The same ATC class is registered in 8 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Reboxetine is registered in 8 of 19 countries.
Countries holding a registration under ATC N06AX18 (reboxetine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Reboxetine · ATC N06AX18
8 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Ireland
- Italyprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of reboxetine costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $1.04 in Italy to $2.27 in Switzerland — a ×2.2 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Reboxetine · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.27
- IT Italy$1.04
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Reboxetine
- Manufacturer
- Imported
- Country
- United Kingdom (GB)
- ATC code
- N06AX18
- ATC class
- Reboxetine
- Defined daily dose
- 8 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for reboxetine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Reboxetine · interactions on record
19 records
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Reboxetine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenEdronax 4 mg TablettOrifarm AB
- SpainIRENOR 4 mg COMPRIMIDOSPfizer S.L.
- FinlandEdronaxPfizer Oy
- SwitzerlandEdronax, Tabletten 4 mgPfizer AG
- IrelandEdronax® 4 mg tabletsPfizer Healthcare Ireland Unlimited Company
- PolandEdronaxPfizer Europe MA EEIG
- ItalyEDRONAX*20 cpr 4 mgPFIZER ITALIA Srl
- BelgiumEdronax 4 mgPfizer
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Edronax
- Belgium · Edronax
- Bulgaria · Едронакс
- Germany · Edronax
- Spain · Irenor, Norebox
- Croatia · Edronax
- Ireland · Edronax
- Italy · Edronax
- Luxembourg · Edronax
- Poland · Edronax
- Portugal · Edronax
- Sweden · Edronax
- Slovenia · Edronax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cec8327e-bad0-4a7c-ab0a-14c64d0a9283 GET /v1/drugs/cec8327e-bad0-4a7c-ab0a-14c64d0a9283?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42163111000001103",
"desc": "Reboxetine 4mg tablets (Imported)",
"form": "Oral tablet",
"vpid": "39703311000001102",
"source": "dmd",
"vtm_id": "777405000",
"strength": "4 mg",
"substance": "Reboxetine",
"ingredient": "Reboxetine mesilate",
"supplier_code": "38977111000001105"
}See everything about reboxetine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.